Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.52 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.52 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.52 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.48 |
| ▸ | FDPS | P14324 | 1/20 | 0.48 |
| ▸ | LAP3 | P28838 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dodecylamine SCHEMBL11346146 | 0.98 | DNM1 (0.59) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Decylamine SCHEMBL5935326 | 0.98 | DNM1 (0.59) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Medronic Acid SCHEMBL11773137 | 0.98 | DNM1 (0.59) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Dodecylamine SCHEMBL28083710 | 0.89 | DNM1 (0.65) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Medronic Acid SCHEMBL8962718 | 0.89 | GABBR2 (0.58) | DNM1TSHRLPAR3LPAR2GABBR2 | |
| Dectaflur SCHEMBL11039514 | 0.87 | SLC6A5 (0.53) | DNM1MEN1KMT2ALPAR3LPAR2 | |
| Dodecylamine SCHEMBL23525472 | 0.86 | DNM1 (0.68) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Dodecylamine SCHEMBL10967256 | 0.86 | DNM1 (0.68) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Dodecylamine SCHEMBL10657644 | 0.86 | DNM1 (0.68) | DNM1MEN1KMT2AALDH1A1TSHR | |
| Tetradecylamine SCHEMBL7641962 | 0.86 | DNM1 (0.68) | DNM1MEN1KMT2AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403707-B2 | Pentaerythritol core, phosphonic acid terminated dendrimer and its preparation method | TONGJI UNIVERSITY (CN) | 2016-08-02 | — | — | US | disclosed |
| US-9403853-B2 | Trimethylolpropane core, phosphonic acid terminated dendrimer and its preparation method | TONGJI UNIVERSITY (CN) | 2016-08-02 | — | — | US | disclosed |
| US-20140332471-A1 | Pentaerythritol core, phosphonic acid terminated dendrimer and its preparation method | TONGJI UNIVERSITY (CN) | 2014-11-13 | — | — | US | disclosed |
| US-20140332470-A1 | Trimethylolpropane core, phosphonic acid terminated dendrimer and its preparation method | TONGJI UNIVERSITY (CN) | 2014-11-13 | — | — | US | disclosed |
| US-20140319064-A1 | Ethylenediamine core, octamethylenephosphonic acid terminated, PAMAM dendrimer and its use as antiscalant | TONGJI UNIVERSITY | 2014-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140332470-A1 | Trimethylolpropane core, phosphonic acid terminated dendrimer and its preparation method | PHOSPHO1, CACNA1H, KCNN2 | DNM1 129/4885MEN1 900/4885KMT2A 2773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.